Peripheral neuropathy can be caused by compression of a nerve (like carpal tunnel syndrome), physical injury to a nerve such ...

Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to ...

No statistical difference was reported in time to onset of CIPN between the 2 groups. Additionally, 75% of the patients undergoing treatment with gemcitabine plus albumin-bound paclitaxel did not ...

University of California, San Diego-led research suggests that long-term variability in blood pressure is associated with ...

This review will focus on the determinants and treatment stratagems of peripheral edema in patients being treated with CCBs. This is a common clinical problem and often is a significant deterrent ...

For columnist Leigh Anne Nelson, multiple sclerosis has resulted in numbness, tingling, and a lack of coordination in her ...

NORTH CHICAGO, IL, USA I 18, 2024 I AbbVie (NYSE: ABBV) today announced the European Commission (EC) granted marketing authorization for ELAHERE® ...

A preliminary study of an artificial intelligence-powered program found that it could detect if a person had high blood ...

There was no treatment effect of durvalumab across all subgroups ... creatinine clearance <60 mL/min, hearing impairment, ...

Laser therapies may help with pain after a root canal, but a review of published studies shows their effectiveness can vary significantly. Further research is needed to identify the optimal approach.

Currently, there is no FDA-approved treatment for cancer anorexia cachexia syndrome ... with initial clinical development planned for chemotherapy-induced peripheral neuropathy (CIPN). Fatty Acid ...

Karyopharm Therapeutics Inc. (Nasdaq: KPTI ), a commercial-stage Pharmaceutical company pioneering novel cancer therapies, today announced abstracts detailing selinexor data have been selected to be ...